OPHiA DDM™ HRD Solution will help empower clinical researchers to advance cancer research BOSTON and LAUSANNE, Switzerland SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Tel Aviv Sourasky Medical Center (Ichilov), the largest acute care facility in Israel, has chosen to use […]
SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has already exceeded more than 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. The orders represent a diverse customer base spanning research and clinical customer segments in nearly 30 […]
Zurich, Switzerland – BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Dr Carolin Bender as the company’s first Chief Medical Officer. BCP’s new CMO will be overseeing the operational work underpinning the company’s rapidly expanding global patient data sourcing and data network development, which provides customers with […]
Scientists to receive technical support, personalized training Madison, WI USA. — Early-career researchers working with real-time quantitative PCR (qPCR) can advance their project through a grant offered by Promega Corporation. The 2023 qPCR Grant will award $15,000 in free Promega products to three academic life scientists incorporating the technique into their research. Applications will be […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission’s (“FTC”) decision ordering the unwinding of Illumina’s acquisition of GRAIL. Illumina intends to file a petition for review promptly with a US Court of Appeals and will seek expedited treatment of the appeal. The FTC’s order to unwind the […]
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to […]
France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros Aubagne — Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to […]
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announces its participation in a cohort study led by the UK National Institute for Health and Care Research (NIHR) BioResource to further explore human health and disease. The study would involve using Oxford Nanopore’s platform to sequence up to 22,000 […]
TATAA Biocenter, a leading provider of high-quality molecular analysis services, announced today that it has become a certified Qualified Service Provider for HTG Molecular Diagnostics. This certification will enable TATAA to offer high-throughput, multiplex gene expression profiling to its customers, and expand its portfolio of molecular analysis services. HTG Molecular Diagnostics is a life science […]
HUNTSVILLE, Ala. —Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial service laboratory in the world to receive two of the new NovaSeqTM X Plus Sequencing Systems from Illumina, Inc. Discovery Genomics will expand its platform to five systems by the end of the year―positioning itself as […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
